SILEXION THERAPEUTICS CORP Increase (Decrease) in Accounts and Other Receivables
SILEXION THERAPEUTICS CORP (SLXN) reported Increase (Decrease) in Accounts and Other Receivables of -$4.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2025-05-13
- SILEXION THERAPEUTICS CORP increase (decrease) in accounts and other receivables for the quarter ending 2025-03-31 was -$4.00K, a 109.09% decline year-over-year.
- SILEXION THERAPEUTICS CORP increase (decrease) in accounts and other receivables for the quarter ending 2024-09-30 was $17.00K.
- SILEXION THERAPEUTICS CORP increase (decrease) in accounts and other receivables for the quarter ending 2024-06-30 was -$2.00K, a 110.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP increase (decrease) in accounts and other receivables for the quarter ending 2024-03-31 was $44.00K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month |
|---|---|---|---|
| 2025-03-31 | -$4.00K 10-Q · filed 2025-05-13 | ||
| 2024-09-30 | $17.00K 10-Q · filed 2024-11-14 | $15.00K derived: sum of 2 quarters · filed 2024-11-14 | $59.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$2.00K 10-Q · filed 2024-08-29 | $42.00K 10-Q · filed 2024-08-29 | |
| 2024-03-31 | $44.00K 10-Q · filed 2025-05-13 | ||
| 2023-09-30 | -$24.00K 10-Q · filed 2024-11-14 | -$4.00K derived: sum of 2 quarters · filed 2024-11-14 | -$15.00K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $20.00K 10-Q · filed 2024-08-29 | $9.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |